24 May 2025
Cancers | Editor’s Choice Articles Published in 2024 and Special Issues in the “Cancer Therapy” Section

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some of the most viewed papers in the “Cancer Therapy” Section that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, a few Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that may be of interest to you.
The list of relevant papers can be seen below:
“Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy”
by Ryungsa Kim, Takanori Kin and William T. Beck
Cancers 2024, 16(5), 984; https://doi.org/10.3390/cancers16050984
Available online: https://www.mdpi.com/2072-6694/16/5/984
“Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review”
by Filippo Lococo, Galal Ghaly, Marco Chiappetta, Sara Flamini, Jessica Evangelista, Emilio Bria, Alessio Stefani, Emanuele Vita, Antonella Martino, Luca Boldrini et al.
Cancers 2024, 16(10), 1832; https://doi.org/10.3390/cancers16101832
Available online: https://www.mdpi.com/2072-6694/16/10/1832
“Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer”
by Brittney S. Zimmerman and Francisco J. Esteva
Cancers 2024, 16(4), 800; https://doi.org/10.3390/cancers16040800
Available online: https://www.mdpi.com/2072-6694/16/4/800
“Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions”
by Rohan Kalyan Rej, Joyeeta Roy and Srinivasa Rao Allu
Cancers 2024, 16(3), 552; https://doi.org/10.3390/cancers16030552
Available online: https://www.mdpi.com/2072-6694/16/3/552
“Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance”
by Anna Fateeva, Kevinn Eddy and Suzie Chen
Cancers 2024, 16(8), 1571; https://doi.org/10.3390/cancers16081571
Available online: https://www.mdpi.com/2072-6694/16/8/1571
Special Issues:
“Multimodal Treatment for Pancreatic Cancer”
|
“Advancing Horizons in Colorectal Surgery: Innovative Approaches and Outcomes” |
![]() |
![]() |
“Research on Early-Stage Breast Cancer: Management and Treatment” |
“New Approaches in Radiotherapy for Cancer” |
![]() |
![]() |
You are invited to view and submit relevant papers to the journal Cancers at the following link: https://www.mdpi.com/journal/cancers.
Cancers Editorial Office